Test Treat Strategy to Prevent Ulcerative Colitis Relapse

Trial Profile

Test Treat Strategy to Prevent Ulcerative Colitis Relapse

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs Mesalazine (Primary)
  • Indications Ulcerative colitis
  • Focus Pharmacokinetics
  • Acronyms DEAR
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Apr 2011 Planned End Date changed from 1 Dec 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.
    • 07 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top